Ann Rhoads's Trading History
| GMEDGlobus Medical | Jun 08, 2026 | Director | Uninformative Buy | 656.75K | $3.15M | |
| QDELQuidelOrtho | Jun 02, 2026 | Director | Uninformative Buy | ― | $308.16K | |
| RPTXRepare Therapeutics | Jan 28, 2026 | ― | Uninformative Sell | ― | $0.00 | |
| FTSVForty Seven | Apr 07, 2020 | ― | Uninformative Sell | ― | $0.00 | |
| IRIXIridex | Jun 15, 2018 | Director | Uninformative Buy | ― | $4.05K | |
| ZGNXZogenix | Jun 04, 2014 | ― | Informative Sell | 38.00 | $12.54M | |
| ALPNAlpine Immune Sciences | Jun 06, 2012 | ― | Uninformative Sell | ― | $0.00 | |
| EVOKEvoke Pharma | ― | ― | ― | $0.00 | ||
| ITOSiTeos Therapeutics | ― | ― | ― | ― |
You May Also Like
Ann Rhoads insider profile FAQ
What is the percentage of profitable transactions made by Ann Rhoads?
The percentage of profitable transactions made by Ann Rhoads is 80%.
What is the average return per transaction made by Ann Rhoads?
The average return per transaction made by Ann Rhoads is -3.60%.
What stocks does Ann Rhoads hold?
Ann Rhoads holds: QDEL, IRIX, ZGNX, FTSV, RPTX, ITOS, GMED, EVOK, ALPN stocks.
What was Ann Rhoads’s latest transaction?
Ann Rhoads’s latest transaction was an Uninformative Buy of $656.75K.
What was Ann Rhoads's most profitable transaction?
Ann Rhoads’s most profitable transaction was an Informative Sell of GMED stock on September 17, 2024. The return on the trade was 18.90%.
What is Ann Rhoads's role in QuidelOrtho?
Ann Rhoads's role in QuidelOrtho is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.